Perrigo Company PLC (NYSE:PRGO) Director Theodore R. Samuels II acquired 4,000 shares of the business’s stock in a transaction dated Friday, August 9th. The stock was purchased at an average cost of $46.97 per share, for a total transaction of $187,880.00. Following the transaction, the director now owns 8,236 shares in the company, valued at $386,844.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
NYSE:PRGO opened at $45.67 on Friday. The company has a market cap of $6.50 billion, a PE ratio of 10.04, a P/E/G ratio of 2.88 and a beta of 1.40. Perrigo Company PLC has a twelve month low of $36.28 and a twelve month high of $78.90. The company has a current ratio of 1.92, a quick ratio of 1.14 and a debt-to-equity ratio of 0.54. The company’s 50 day moving average is $50.54 and its two-hundred day moving average is $48.49.
Perrigo (NYSE:PRGO) last released its earnings results on Thursday, August 8th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.05. Perrigo had a net margin of 1.87% and a return on equity of 9.57%. The company had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.13 billion. During the same quarter in the previous year, the firm earned $1.22 EPS. Perrigo’s revenue was down 3.2% compared to the same quarter last year. As a group, analysts expect that Perrigo Company PLC will post 3.95 EPS for the current fiscal year.
A number of hedge funds and other institutional investors have recently made changes to their positions in PRGO. SRS Capital Advisors Inc. acquired a new stake in Perrigo during the 2nd quarter valued at approximately $25,000. Financial Gravity Wealth Inc. lifted its stake in Perrigo by 15,075.0% during the 2nd quarter. Financial Gravity Wealth Inc. now owns 607 shares of the company’s stock valued at $29,000 after acquiring an additional 603 shares during the period. Parallel Advisors LLC lifted its stake in Perrigo by 833.7% during the 1st quarter. Parallel Advisors LLC now owns 803 shares of the company’s stock valued at $39,000 after acquiring an additional 717 shares during the period. Advisor Group Inc. lifted its stake in Perrigo by 822.2% during the 4th quarter. Advisor Group Inc. now owns 1,079 shares of the company’s stock valued at $41,000 after acquiring an additional 962 shares during the period. Finally, Commonwealth Bank of Australia lifted its stake in Perrigo by 295.6% during the 2nd quarter. Commonwealth Bank of Australia now owns 890 shares of the company’s stock valued at $42,000 after acquiring an additional 665 shares during the period. Institutional investors and hedge funds own 85.94% of the company’s stock.
Several analysts have weighed in on PRGO shares. Cantor Fitzgerald dropped their target price on shares of Perrigo from $107.00 to $60.00 and set an “overweight” rating on the stock in a research report on Wednesday, June 12th. SunTrust Banks boosted their target price on shares of Perrigo to $51.00 and gave the stock a “hold” rating in a research report on Monday, May 20th. ValuEngine raised shares of Perrigo from a “strong sell” rating to a “sell” rating in a research report on Thursday, August 1st. Finally, Wells Fargo & Co reissued a “hold” rating on shares of Perrigo in a research report on Tuesday, July 2nd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $59.50.
Perrigo Company Profile
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
See Also: What is an SEC Filing?
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.